Xencor (XNCR) FCF Margin (2013 - 2026)

Xencor (XNCR) posted quarterly FCF Margin of 1511.03% for Q1 2026, down 145706.0% year-over-year from N/an in Q1 2025, and down 707.31% quarter-over-quarter from 187.17% in Q4 2025.

Xencor (XNCR) FCF Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported FCF Margin for 14 consecutive years, with 1511.03% the latest figure, recorded in Q1 2026.

  • In Q1 2026, FCF Margin fell 145706.0% year-over-year to 1511.03%; the TTM figure through Mar 2026 stood at 193.96% (down 6116.0% YoY), while the FY2025 annual figure was 110.11%, up 7840.0% from the prior year.
  • FCF Margin fell to 1511.03% in Q1 2026 per XNCR's latest filing, from 187.17% in the prior quarter.
  • Across five years, FCF Margin topped out at 105.68% in Q2 2022 and bottomed at 1511.03% in Q1 2026.
  • Historically, FCF Margin has averaged 195.88% across 5 years, with a median of 97.55% in 2024.
  • Annual changes were most pronounced in 2025 — FCF Margin jumped 30230 bps — and 2026, when it slumped 145706 bps.
  • Xencor's FCF Margin stood at 159.17% in 2022, then jumped by 121 bps to 33.69% in 2023, then plunged by 390 bps to 97.55% in 2024, then slumped by 92 bps to 187.17% in 2025, then tumbled by 707 bps to 1511.03% in 2026.
  • Business Quant data shows XNCR's FCF Margin at 1511.03% in Q1 2026, 187.17% in Q4 2025, and 147.63% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 13.35%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.68%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,594.17%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 70.82%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 22.62%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -22.35%
10 Xencor 1.73 Bn 1.36 Bn - -109.71%

Historic Data

Download Data
DateValue
Jun 30, 2026 -109.71%
Mar 31, 2026 -1,511.03%
Dec 31, 2025 -187.17%
Sep 30, 2025 -147.63%
Jun 30, 2025 -84.28%
Mar 31, 2025 -53.97%
Dec 31, 2024 -97.55%
Sep 30, 2024 -165.30%
Jun 30, 2024 -294.37%
Mar 31, 2024 -356.26%
Dec 31, 2023 33.69%
Sep 30, 2023 -50.87%
Jun 30, 2023 -92.42%
Mar 31, 2023 -217.88%
Dec 31, 2022 -159.17%
Sep 30, 2022 -55.87%
Jun 30, 2022 105.68%
Mar 31, 2022 4.36%
Dec 31, 2021 36.02%
Sep 30, 2021 -212.20%